Chemotherapy in Combination With Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma: CSCO and ASCO GuidelineYu‐Pei Chen, A. Dimitrios Colevas, Robert I. Haddad et al.|Journal of Clinical Oncology|2021Cited by 393
Preclinical activity of gefitinib in non-keratinizing nasopharyngeal carcinoma cell lines and biomarkers of responseBrigette Ma, Anthony T.�C. Chan|Investigational New Drugs|2009Cited by 44